Industrial biocatalysis (enzymes and whole cells) — e.g. nitrile hydratase for acrylamide, engineered transaminase for sitagliptin, enzymatic antibiotic side-chain processes — instead of heavy-metal catalysts, high-pressure hydrogenation and multistep chemistry with toxic reagents

Replaces: heavy-metal catalysis and harsh multistep chemistry · Scope: chemical and pharmaceutical industries · Evidence: high

The chemical problem#

Classical chemical processes often need heavy-metal catalysts, extreme temperatures and pressures, chlorinated solvents and toxic reagents, and they produce large amounts of waste per kilogram of product. This is especially true in pharmaceuticals, where it is common to generate 25–100 kg of waste per kg of product.

Product overview#

Enzymes work in water, at mild temperature and pressure, and with high selectivity. Proven industrial examples:

1. Acrylamide via nitrile hydratase (Rhodococcus rhodochrous J1): Nitto Chemical (Japan) since the mid-1980s; now hundreds of thousands of tonnes/year worldwide, replacing the copper-catalysed sulfuric-acid process. It gives higher purity, and no copper waste.
2. Sitagliptin (Januvia) via an engineered transaminase (Merck & Codexis, Science 2010): replaced rhodium-catalysed high-pressure hydrogenation. Productivity rose, waste fell by about 19 %, and heavy-metal removal and high-pressure equipment were no longer needed (US EPA Presidential Green Chemistry Award, 2010).
3. Semi-synthetic penicillins/cephalosporins (6-APA, 7-ADCA) via penicillin G acylase: replaced chemical deacylation that used chlorinated solvents at −40 °C (DSM and others).
4. Enzymatic interesterification of fats (lipases), replacing chemical catalysts and avoiding trans fats from partial hydrogenation.
5. High-fructose syrup and starch processing with enzymes instead of acid hydrolysis.

Active ingredient / Composition#

Enzymes produced by fermentation (often engineered by directed evolution), immobilized enzymes, whole-cell biocatalysts.

Key facts#

Advantages#

• Eliminates heavy metals and many hazardous reagents and solvents.
• Lower energy use and waste.
• Higher product purity (important for pharma and polymers).

Mode of action#

Enzymes lower the activation energy of specific reactions through precise active-site chemistry, so selective transformations happen under mild conditions without protecting groups.

Application#

Limitations#

• Developing an enzyme process takes time (enzyme engineering, stability).
• Not every reaction type has a suitable enzyme yet.
• Aqueous processes may need different downstream processing.

Evidence of displacement — D2: measurable displacement (minority share)#

Assessment (hand-reviewed): Global: >300 industrial biocatalytic processes documented (peer-reviewed). A market-research site puts enzymatic hydration at 58% of bio-based acrylamide revenue — weak source, not counted.

Verified figures (the number is in the quoted sentence and the sentence is on the source page):

• displacement — A biocatalytic process for simvastatin manufacture was scaled to 400 kg batch size and over 10 metric tons of simvastatin have been produced using this method. (global, 2010-2012; weak: cs.gordon.edu)
• displacement — The enzymatic hydration route for acrylamide production accounted for 58.4% of total global bio-based acrylamide market revenues in 2025. (global, 2025; weak: marketintelo.com)
• performance — The enzymatic route for Sitagliptin synthesis resulted in 53% higher productivity compared to the previously used chemical process with a Rh-t-Bu-Josiphos catalyst. (global, 2010-2020 period (contextual); peer-reviewed: onlinelibrary.wiley.com)
• performance — In the synthesis of boceprevir, an evolved monoamine oxidase replaced a synthetic resolution step, increasing product yield by 150% and reducing overall process waste (E-factor) by 63.1%. (global, 2025; weak: comptes-rendus.academie-sciences.fr)

Industry pioneers — companies that commercialised this substitution#

Suppliers — real products and services (from the vendor index)#

Companies below are active vendors in the vendor index whose own card (profile / official website) shows this product or service — matched 2026-09-28 by keyword and checked by hand against the card text. Being listed is not an endorsement; open each card for evidence, contacts and status.

Government funding signals#

Public grants for a specific technology are a leading indicator: governments fund what regulators want to replace and what is close to practical adoption. Searched on 2026-09-27 in: EU CORDIS (FP7, Horizon 2020, Horizon Europe), US federal awards (USAspending: USDA NIFA/ARS/APHIS/Forest Service, EPA, DOE, NOAA, USAID; plus NSF and NIH), UK UKRI Gateway to Research, Australian Research Council. Each grant below was reviewed by hand for relevance. China, Brazil and India are covered in the subsection below (publication-acknowledged grants). Not covered: Russia (RSF, FASIE — not reachable from the research environment) and national agencies outside these databases. Amounts are the funder’s contribution as recorded (US NIH/UKRI: per award or fiscal year).

Signal: Strong. 3 relevant grant(s) · about €14.1M in total · jurisdictions: EU, UK, USA.

China, Brazil, India — national research grants acknowledged in publications#

Chinese, Brazilian and Indian funders have no open grant databases reachable here, so this measures scientific papers published since 2015 that acknowledge national government grants, taken from the grant numbers publishers deposit with Crossref. Only papers whose title contains this article’s key terms are counted (a conservative lower bound; “100+” = search window full). It shows research-funding intensity, not budgets. Funders: China — NSFC, National Key R&D Program, China Agriculture Research System; Brazil — CNPq, CAPES, FAPESP, Embrapa, FAPEMIG; India — DBT, DST, ICAR, SERB, CSIR, BIRAC. Rating per country: Strong ≥50 papers · Moderate 10–49 · Weak 1–9.

Scientific evidence#

• Savile CK, Janey JM, Mundorff EC, et al. (2010). Biocatalytic asymmetric synthesis of chiral amines from ketones applied to sitagliptin manufacture. Science 329: 305–309.
• Yamada H, Kobayashi M (1996). Nitrile hydratase and its application to industrial production of acrylamide. Bioscience, Biotechnology, and Biochemistry 60: 1391–1400.
• Sheldon RA, Woodley JM (2018). Role of biocatalysis in sustainable chemistry. Chemical Reviews 118: 801–838.

Bioeconomy value#

Fermentation-made enzymes turn chemical manufacturing into biotechnology, the core of the industrial bioeconomy.